Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial
蛋白C激活剂AB002在接受血液透析的终末期肾病患者中的安全性和耐受性:一项随机II期试验
期刊:
影响因子:
doi:10.1038/s43856-024-00575-y
Verbout, Norah G; Lorentz, Christina U; Markway, Brandon D; Wallisch, Michael; Marbury, Thomas C; Di Cera, Enrico; Shatzel, Joseph J; Gruber, András; Tucker, Erik I